Product
SARS-CoV-2 Variant mRNA vaccine
2 clinical trials
1 indication
Indication
COVID-19Clinical trial
A Preliminary Exploratory Cohort Study to Evaluate Safety, Tolerability and Immunogenicity of SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine (LVRNA012) in Participants Aged 18 Years and Over in ChinaStatus: Active (not recruiting), Estimated PCD: 2022-12-19
Clinical trial
A Single-center, Randomized, Blinded, Placebo-controlled Clinical Trial to Evaluate the Protective Efficacy, Safety and Immunogenicity of One Dose of the SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine in People Aged 18 Years and Older Who Had Received Two or Three Doses of Inactivated COVID-19 VaccineStatus: Recruiting, Estimated PCD: 2023-09-01